syn-Selective catalytic asymmetric nitro-Mannich reactions using a heterobimetallic Cu/Sm/Schiff base complex are described. The present method is complementary to the previously reported methods, and products were obtained in high syn-selectivity (>20:1), yield (99−62%), and enantioselectivity (98−83% ee). Both Cu and Sm metals, aligned suitably in a dinucleating Schiff base ligand, were essential to realize high syn-selectivity.
The full details of a catalytic asymmetric syn-selective nitro-Mannich reaction promoted by heterobimetallic Cu/Sm/dinucleating Schiff base complexes are described, demonstrating the effectiveness of the heterobimetallic transition metal/rare earth metal bifunctional catalysis. The first-generation system prepared from Cu(OAc)(2)/Sm(O-iPr)(3)/Schiff base 1a = 1:1:1 with an achiral phenol additive was partially successful for achieving the syn-selective catalytic asymmetric nitro-Mannich reaction. The substrate scope and limitations of the first-generation system remained problematic. After mechanistic studies on the catalyst prepared from Sm(O-iPr)(3), we reoptimized the catalyst preparation method, and a catalyst derived from Sm(5)O(O-iPr)(13) showed broader substrate generality as well as higher reactivity and stereoselectivity compared to Sm(O-iPr)(3). The optimal system with Sm(5)O(O-iPr)(13) was applicable to various aromatic, heteroaromatic, and isomerizable aliphatic N-Boc imines, giving products in 66-99% ee and syn/anti = >20:1-13:1. Catalytic asymmetric synthesis of nemonapride is also demonstrated using the catalyst derived from Sm(5)O(O-iPr)(13).
Chiral b-amino alcohols are useful building blocks found in various biologically active natural products, pharmaceuticals, chiral auxiliaries, and chiral ligands.[1] Various methods for catalytic enantioselective synthesis of b-amino alcohols have been developed over the past decade, [2] and the catalytic asymmetric nitroaldol (Henry) reaction is an efficient method for providing b-amino alcohols by reduction of the nitro moiety in nitroaldol adducts.[3] Since our first report of the catalytic asymmetric nitroaldol reaction, [4] various chiral catalysts, which are effective with nitromethane as a donor, have been developed.[5] However, diastereo-and enantioselective nitroaldol reactions that use nitroethane and other nitroalkanes as donors are limited. To realize direct nitroaldol reactions, chiral Brønsted base catalysts could deprotonate the a proton of the nitroalkane to generate a metal nitronate, but epimerization of the products must be prevented to achieve high diastereoselectivity under kinetic control. Synselective asymmetric reactions have been established by our group and others; [6] but anti-selective asymmetric reactions required pre-activation of nitroalkanes to silylnitronates [7] to avoid basic conditions. Therefore, a new catalyst for antiselective asymmetric nitroaldol reactions for direct use with nitroalkanes is needed in terms of atom economy.[8] Quite recently, Ooi and co-workers [9] reported an elegant chiral Pspiro triaminoiminophosphorane catalyst for the first direct nitroaldol reaction with excellent anti selectivity, enantioselectivity, and broad substrate generality. [10][11] Considering the importance of anti amino alcohols as precursors for various important pharmaceuticals such as b-adrenoceptor agonists, additional studies of the anti-selective reactions are desirable. Herein, we report a new heterobimetallic Pd/La/1 complex (Scheme 1) for anti-selective nitroaldol reactions, and its application to short syntheses of b-adrenoceptor agonists 2 a·HCl (ritodrine·HCl) and 2 b·HCl.2 a·HCl is a selective b 2 -adrenoceptor agonist, clinically used for the prevention of pre-term birth (Scheme 2), [12] and related compound 2 b·HCl is a selective b 3 -adrenoceptor agonist that provides a new therapeutic for urinary dysfunction.[13] The common chiral anti b-amino alcohol unit (4'-hydroxynorephedrine) in both drugs is key for high biological activity, and we anticipated the anti-nitroaldol reaction to be one of the most straightforward methods for constructing two contiguous stereocenters in the common unit (Scheme 2). 2 a and 2 b could be synthesized by reduction of the nitro group of the anti-nitroaldol adduct with subsequent reductive alkylation of the amine moiety. Initially, we planned to utilize antiselective nitroaldol reactions catalyzed by a Nd/Na/chiral amide complex recently developed by our group, [11] but when used with aldehyde precursors suitable for 2 a and 2 b the reactions resulted in low enantioselectivities of the prod- Scheme 2. Structures and retrosynthesis of (À)-rito...
Stereodivergent construction of three contiguous stereocenters in catalytic doubly diastereoselective nitroaldol reactions of alpha-chiral aldehydes with nitroacetaldehyde dimethyl acetal using two types of heterobimetallic catalysts is described. A La-Li-BINOL (LLB) catalyst afforded anti,syn-nitroaldol products in >20:1-14:1 selectivity, and a Pd/La/Schiff base catalyst afforded complimentary syn,syn-nitroaldol products in 10:1-5:1 selectivity.
Out of options? Even though a systematic approach was chosen, which led to a set of four diastereomeric macrolides modeled around the proposed structure of leiodolide B (see picture), the puzzle concerning the stereostructure of this cytotoxic metabolite derived from a deep‐sea sponge still remains unsolved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.